Understanding how a specific protein affects insulin secretion in diabetes
A novel role for 14-3-3-ζ in regulating islet cell crosstalk
This study is looking at a protein called 14-3-3-ζ to see how it helps the cells in your pancreas communicate with each other, which is important for insulin production, especially for people with type 2 diabetes, to find new ways to improve insulin release and blood sugar control.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10998351 on NIH RePORTER |
What this research studies
This research investigates the role of the protein 14-3-3-ζ in regulating communication between pancreatic islet cells, which are crucial for insulin secretion. The study focuses on how this protein influences the function of alpha and beta cells in the pancreas, particularly in the context of type 2 diabetes mellitus. By examining the mechanisms that preserve islet function, the research aims to identify potential therapeutic targets that could enhance insulin secretion and improve glucose regulation. The approach includes both in vitro studies using human and mouse islets to observe the effects of manipulating 14-3-3-ζ levels.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 2 diabetes who may benefit from improved insulin regulation.
Not a fit: Patients with type 1 diabetes or those without any form of diabetes may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve insulin secretion and glucose control for patients with type 2 diabetes.
How similar studies have performed: Previous research has shown promising results in understanding islet cell communication and its impact on diabetes management, suggesting that this approach could yield valuable insights.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Shishani, Rahaf — University of California at Davis
- Study coordinator: Shishani, Rahaf
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.